SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

about

SOCS3 expression correlates with severity of inflammation, expression of proinflammatory cytokines, and activation of STAT3 and p38 MAPK in LPS-induced inflammation in vivo.AG311, a small molecule inhibitor of complex I and hypoxia-induced HIF-1α stabilization.

P2860

Q39089939-BEED7513-37C6-4BBB-9B0C-7D10989F52D9 Q48022535-FFF61D4C-93E3-43B3-A816-E96536B6F0AF

P2860

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

Item

http://www.wikidata.org/entity/Q35966972

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@ast

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@en

type

Item

label

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@ast

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@en

prefLabel

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@ast

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@en

P1476

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

@en

P2093

Bethany M Mickle-Kawar

http://www.w3.org/2001/XMLSchema#string

Lerin R Luckett-Chastain

http://www.w3.org/2001/XMLSchema#string

Michael A Ihnat

http://www.w3.org/2001/XMLSchema#string

P2860

Impaired cutaneous wound healing in interleukin-6-deficient and immunosuppressed mice

Soluble forms of the interleukin-6 signal-transducing receptor component gp130 in human serum possessing a potential to inhibit signals through membrane-anchored gp130

Molecular cloning and expression of an IL-6 signal transducer, gp130

Principles of interleukin (IL)-6-type cytokine signalling and its regulation

The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop

STAT3 serine phosphorylation by ERK-dependent and -independent pathways negatively modulates its tyrosine phosphorylation

The conserved SOCS box motif in suppressors of cytokine signaling binds to elongins B and C and may couple bound proteins to proteasomal degradation

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Cytokine-inducible SH2 protein-3 (CIS3/SOCS3) inhibits Janus tyrosine kinase by binding through the N-terminal kinase inhibitory region as well as SH2 domain

Tyrosine-phosphorylated SOCS-3 inhibits STAT activation but binds to p120 RasGAP and activates Ras

P304

207-215

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1089/JIR.2011.0086

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Randle M. Gallucci

P577

2012-02-07T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221813519

http://www.w3.org/2001/XMLSchema#string

P698

22313262

http://www.w3.org/2001/XMLSchema#string

P932

3354580

http://www.w3.org/2001/XMLSchema#string

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

about

P2860

P2860

SOCS3 modulates interleukin-6R signaling preference in dermal fibroblasts.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P5875

P698

P932